Bioabsorbable Implants Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

Description

Persistence Market Research has recently released a comprehensive report on the worldwide market for bioabsorbable implants. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

Bioabsorbable Implants Market Size (2024E): USD 659.3 million
Projected Market Value (2033F): USD 823.1 million
Global Market Growth Rate (CAGR 2024 to 2033):2.5%

Bioabsorbable Implants Market - Report Scope:

Bioabsorbable implants, made from biodegradable materials, are designed to gradually break down in the body after fulfilling their intended purpose. These implants eliminate the need for a second surgery to remove them, making them popular in various medical procedures, particularly in orthopedics, cardiovascular surgery, and tissue repair. The market caters to hospitals, specialty clinics, and outpatient surgical centers, offering a range of implant types, including plates, screws, pins, and meshes made from materials like polylactic acid (PLA) and polyglycolic acid (PGA).

Market Growth Drivers:

The global bioabsorbable implants market is driven by several factors, including the increasing demand for minimally invasive surgeries and the growing prevalence of orthopedic and cardiovascular conditions. Advances in material science, such as the development of new polymers and composites that enhance the bioabsorption process, are driving market innovation. The rising geriatric population and the increasing number of sports-related injuries also contribute to the demand for bioabsorbable implants, as these patients benefit from implants that reduce long-term complications and improve recovery times.

Market Restraints:

Despite promising growth prospects, the bioabsorbable implants market faces challenges related to high manufacturing costs and regulatory hurdles. The rigorous approval processes for bioabsorbable materials, especially in regions with stringent healthcare regulations, can delay market entry and increase development costs. Additionally, the limited availability of clinical data demonstrating long-term outcomes of bioabsorbable implants compared to traditional metal implants poses a challenge for market penetration.

Market Opportunities:

The bioabsorbable implants market presents significant growth opportunities through technological advancements and the expansion of their application areas. Research into new bioabsorbable materials with enhanced mechanical properties and controlled degradation rates is expected to drive future market growth. Furthermore, the increasing use of bioabsorbable implants in areas such as maxillofacial surgery and pediatric care, where long-term implantation may pose risks, is creating new avenues for market expansion. Partnerships between medical device manufacturers and healthcare providers will also be crucial in promoting the adoption of bioabsorbable implants.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the bioabsorbable implants market globally?
Which implant types and medical procedures are driving bioabsorbable implant adoption across different healthcare settings?
How are technological advancements reshaping the competitive landscape of the bioabsorbable implants market?
Who are the key players contributing to the bioabsorbable implants market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global bioabsorbable implants market?

Competitive Intelligence and Business Strategy:

Leading players in the global bioabsorbable implants market, including Stryker Corporation, Zimmer Biomet, and Johnson & Johnson, focus on innovation and product differentiation to gain a competitive edge. These companies invest in research and development to enhance the performance and safety of bioabsorbable implants, catering to the evolving needs of patients and surgeons. Strategic partnerships and collaborations with healthcare providers and research institutions enable these players to expand their market presence. Additionally, companies are increasingly focusing on clinical trials and obtaining regulatory approvals to bolster product credibility and market acceptance.

Key Companies Profiled:

Stryker Corporation
Zimmer Biomet
Johnson & Johnson
Smith & Nephew
Medtronic Plc
Boston Scientific Corporation
Bioretec Ltd.
Orthocell Ltd.
KLS Martin Group
DePuy Synthes

Key Segments of Bioabsorbable Implant Market Research

By Product Type :

Stents
Biological Meshes
Fixation Devices

By Material :

Metallic
Ceramic
Polymers

By Application :

Orthopedic
Cardiovascular
By End User :
Hospitals
Ambulatory Surgical Centers
Specialty Clinics

By Region :

North America
Latin America
Europe
East Asia
South Asia & Oceania
Middle East & Africa

Product Code: PMRREP28057

1. Executive Summary

1.1. Global Market Outlook
1.2. Trends
1.3. Top Players for Bioabsorbable Implants Market
1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations

3. Key Success Factors

3.1. Product Adoption / Usage Analysis
3.2. Iceberg Analysis
3.3. Regulatory Scenario
3.4. Reimbursement Scenario
3.5. Comparison of Products

4. Global Bioabsorbable Implants Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

4.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
4.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
- 4.2.1. Y-o-Y Growth Trend Analysis
- 4.2.2. Absolute $ Opportunity Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Industry Market Outlook
- 5.1.3. Regulatory Scenario
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Manufacturers expanding their distribution channel
- 5.2.2. Alternative Product Availability
- 5.2.3. Alternative Product Availability
- 5.2.4. Technology advancements
5.3. Value Chain
5.4. Market Dynamics
- 5.4.1. Drivers
- 5.4.2. Restraints
- 5.4.3. Opportunity Analysis

6. Global Bioabsorbable Implants Market Analysis 2019-2023 and Forecast 2024-2033, by Product Type

6.1. Introduction / Key Findings
6.2. Historical Market Size (US$ Mn) Analysis by Product Type, 2019-2023
6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Product Type, 2024-2033
- 6.3.1. Stents
  - 6.3.1.1. Coronary Artery Stents
  - 6.3.1.2. Peripheral Artery Stents
  - 6.3.1.3. Non vascular Stents
    - 6.3.1.3.1. Esophageal Stents
    - 6.3.1.3.2. Biliary stents
- 6.3.2. Biological Meshes
- 6.3.3. Fixation Devices
6.4. Market Attractiveness Analysis by Product Type

7. Global Bioabsorbable Implants Market Analysis 2019-2023 and Forecast 2024-2033, by Material Type

7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) Analysis by Material Type, 2019-2023
7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Material Type, 2024-2033
- 7.3.1. Metallic
- 7.3.2. Ceramics
- 7.3.3. Polymers
  - 7.3.3.1. PGA (Polyglycolide)
  - 7.3.3.2. PLA (Polylactide)
  - 7.3.3.3. Co-polymers
7.4. Market Attractiveness Analysis by Material Type

8. Global Bioabsorbable Implants Market Analysis 2019-2023 and Forecast 2024-2033, by Application

8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis by Application, 2019-2023
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by Application, 2024-2033
- 8.3.1. Cardiovascular
- 8.3.2. Orthopedics
- 8.3.3. Cosmetic Surgery
- 8.3.4. General Surgery
- 8.3.5. Cranial
- 8.3.6. Others Market Attractiveness Analysis by Application

9. Global Bioabsorbable Implants Market Analysis 2019-2023 and Forecast 2024-2033, by End User

9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2023
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast by End User, 2024-2033
- 9.3.1. Hospitals
- 9.3.2. Specialty Clinics
- 9.3.3. Ambulatory Surgical Centers
9.4. Market Attractiveness Analysis by End User

10. Global Bioabsorbable Implants Market Analysis 2019-2023 and Forecast 2024-2033, by Region

10.1. Introduction
10.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2023
10.3. Current Market Size (US$ Mn) Analysis and Forecast by Region, 2024-2033
- 10.3.1. North America
- 10.3.2. Latin America
- 10.3.3. Europe
- 10.3.4. Middle East and Africa (MEA)
- 10.3.5. East Asia
- 10.3.6. South Asia
- 10.3.7. Oceania
10.4. Market Attractiveness Analysis by Region

11. North America Bioabsorbable Implants Market Analysis 2019-2023 and Forecast 2024-2033

11.1. Introduction
11.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
- 11.3.1. By Country
  - 11.3.1.1. U.S.
  - 11.3.1.2. Canada
- 11.3.2. By Product Type
- 11.3.3. By Material Type
- 11.3.4. By End User
11.4. Market Attractiveness Analysis
- 11.4.1. By Country
- 11.4.2. By Product Type
- 11.4.3. By Material Type
- 11.4.4. By End User
11.5. Key Market Participants - Intensity Mapping
11.6. Drivers and Restraints - Impact Analysis

12. Latin America Bioabsorbable Stents Market Analysis 2019-2023 and Forecast 2024-2033

12.1. Introduction
12.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
- 12.3.1. By Country
  - 12.3.1.1. Brazil
  - 12.3.1.2. Mexico
  - 12.3.1.3. Rest of Latin America
- 12.3.2. By Product Type
- 12.3.3. By Material Type
- 12.3.4. By End User
12.4. Market Attractiveness Analysis
- 12.4.1. By Country
- 12.4.2. By Product Type
- 12.4.3. By Material Type
- 12.4.4. By End User
12.5. Key Market Participants - Intensity Mapping
12.6. Drivers and Restraints - Impact Analysis

13. Europe Bioabsorbable Stents Market Analysis 2019-2023 and Forecast 2024-2033

13.1. Introduction
13.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
- 13.3.1. By Country
  - 13.3.1.1. Germany
  - 13.3.1.2. Italy
  - 13.3.1.3. France
  - 13.3.1.4. U.K.
  - 13.3.1.5. Spain
  - 13.3.1.6. Russia
  - 13.3.1.7. Rest of Europe
- 13.3.2. By Product Type
- 13.3.3. By Material Type
- 13.3.4. By End User
13.4. Market Attractiveness Analysis
- 13.4.1. By Country
- 13.4.2. By Product Type
- 13.4.3. By Material Type
- 13.4.4. By End Users
13.5. Key Market Participants - Intensity Mapping
13.6. Drivers and Restraints - Impact Analysis

14. South Asia Bioabsorbable Stents Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. India
  - 14.3.1.2. Thailand
  - 14.3.1.3. Indonesia
  - 14.3.1.4. Malaysia
  - 14.3.1.5. Rest of South Asia
- 14.3.2. By Product Type
- 14.3.3. By Material Type
- 14.3.4. By End User
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Product Type
- 14.4.3. By Material Type
- 14.4.4. By End User
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis

15. East Asia Bioabsorbable Stents Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. China
  - 15.3.1.2. Japan
  - 15.3.1.3. South Korea
- 15.3.2. By Product Type
- 15.3.3. By Material Type
- 15.3.4. By End User
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Product Type
- 15.4.3. By Material Type
- 15.4.4. By End User
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis

16. Oceania Bioabsorbable Stents Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. Australia
  - 16.3.1.2. New Zealand
- 16.3.2. By Product Type
- 16.3.3. By Material Type
- 16.3.4. By End User
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Product Type
- 16.4.3. By Material Type
- 16.4.4. By End User
16.5. Key Market Participants - Intensity Mapping
16.6. Drivers and Restraints - Impact Analysis

17. Middle East and Africa Bioabsorbable Stents Market Analysis 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Mn) Trend Analysis by Market Taxonomy, 2019-2023
17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. GCC Countries
  - 17.3.1.2. Turkey
  - 17.3.1.3. Northern Africa
  - 17.3.1.4. South Africa
  - 17.3.1.5. Rest of Middle East and Africa
- 17.3.2. By Product Type
- 17.3.3. By Material Type
- 17.3.4. By End User
17.4. Market Attractiveness Analysis
- 17.4.1. By Country
- 17.4.2. By Product Type
- 17.4.3. By Material Type
- 17.4.4. By End User
17.5. Key Market Participants - Intensity Mapping
17.6. Drivers and Restraints - Impact Analysis

18. Emerging Countries Bioabsorbable Stents Market Analysis 2019-2023 and Forecast 2024-2033

18.1. Introduction
- 18.1.1. Market Value Proportion Analysis, By Key Countries
- 18.1.2. Global Vs. Country Growth Comparison
18.2. China Bioabsorbable Stents Market Analysis
- 18.2.1. Introduction
- 18.2.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
  - 18.2.2.1. By Product Type
  - 18.2.2.2. By End User
  - 18.2.2.3. By Material Type
- 18.2.3. China Bioabsorbable Implants Market - Competition Landscape
- 18.2.4. China - Trade Analysis
18.3. Brazil Bioabsorbable Stents Market Analysis
- 18.3.1. Introduction
- 18.3.2. PESTLE Analysis
- 18.3.3. Market and Value (US$ Mn) Analysis and Forecast by Market Taxonomy
  - 18.3.3.1. By Product Type
  - 18.3.3.2. By End User
  - 18.3.3.3. By Material Type
- 18.3.4. Brazil Bioabsorbable Stents Market - Competition Landscape
18.4. Russia Bioabsorbable Stents Market Analysis
- 18.4.1. Introduction
- 18.4.2. PESTLE Analysis
  - 18.4.2.1. By Product Type
  - 18.4.2.2. By End User
  - 18.4.2.3. By Material Type
- 18.4.3. Russia Bioabsorbable Stents Market - Competition Landscape

19. Market Structure Analysis

19.1. Market Analysis by Tier of Companies
19.2. Market Concentration
19.3. Market Share Analysis of Top Players
19.4. Market Presence Analysis
- 19.4.1. Product foot print by Players
- 19.4.2. Channel Foot Print by Players

20. Competition Analysis

20.1. Competition Dashboard
20.2. Pricing Analysis by Competition
20.3. Competition Benchmarking
20.4. Competition Deep Dive
- 20.4.1. Boston Scientific Corporation
  - 20.4.1.1. Overview
  - 20.4.1.2. Product Portfolio
  - 20.4.1.3. Profitability by Market Segments (Product/Channel/Region)
  - 20.4.1.4. Sales Footprint
  - 20.4.1.5. Strategy Overview
    - 20.4.1.5.1. Marketing Strategy
    - 20.4.1.5.2. Product Strategy
- 20.4.2. DENTSPLY Shiroma.
  - 20.4.2.1. Overview
  - 20.4.2.2. Product Portfolio
  - 20.4.2.3. Profitability by Market Segments (Product/Channel/Region)
  - 20.4.2.4. Sales Footprint
  - 20.4.2.5. Strategy Overview
    - 20.4.2.5.1. Marketing Strategy
    - 20.4.2.5.2. Product Strategy
- 20.4.3. Meryl Life Sciences Pvt. Ltd.
  - 20.4.3.1. Overview
  - 20.4.3.2. Product Portfolio
  - 20.4.3.3. Profitability by Market Segments (Product/Channel/Region)
  - 20.4.3.4. Sales Footprint
  - 20.4.3.5. Strategy Overview
    - 20.4.3.5.1. Marketing Strategy
    - 20.4.3.5.2. Product Strategy
- 20.4.4. Medtronic Plc
  - 20.4.4.1. Overview
  - 20.4.4.2. Product Portfolio
  - 20.4.4.3. Profitability by Market Segments (Product/Channel/Region)
  - 20.4.4.4. Sales Footprint
  - 20.4.4.5. Strategy Overview
    - 20.4.4.5.1. Marketing Strategy
    - 20.4.4.5.2. Product Strategy
- 20.4.5. Smith & Nephew Plc
  - 20.4.5.1. Overview
  - 20.4.5.2. Product Portfolio
  - 20.4.5.3. Profitability by Market Segments (Product/Channel/Region)
  - 20.4.5.4. Sales Footprint
  - 20.4.5.5. Strategy Overview
    - 20.4.5.5.1. Marketing Strategy
    - 20.4.5.5.2. Product Strategy
- 20.4.6. Stryker Corporation
  - 20.4.6.1. Overview
  - 20.4.6.2. Product Portfolio
  - 20.4.6.3. Profitability by Market Segments (Product/Channel/Region)
  - 20.4.6.4. Sales Footprint
  - 20.4.6.5. Strategy Overview
    - 20.4.6.5.1. Marketing Strategy
    - 20.4.6.5.2. Product Strategy
- 20.4.7. Wright Medical Group
  - 20.4.7.1. Overview
  - 20.4.7.2. Product Portfolio
  - 20.4.7.3. Profitability by Market Segments (Product/Channel/Region)
  - 20.4.7.4. Sales Footprint
  - 20.4.7.5. Strategy Overview
    - 20.4.7.5.1. Marketing Strategy
    - 20.4.7.5.2. Product Strategy
- 20.4.8. KLS Martin
  - 20.4.8.1. Overview
  - 20.4.8.2. Product Portfolio
  - 20.4.8.3. Profitability by Market Segments (Product/Channel/Region)
  - 20.4.8.4. Sales Footprint
  - 20.4.8.5. Strategy Overview
    - 20.4.8.5.1. Marketing Strategy
    - 20.4.8.5.2. Product Strategy
- 20.4.9. BIOTRONIK Ltd
  - 20.4.9.1. Overview
  - 20.4.9.2. Product Portfolio
  - 20.4.9.3. Profitability by Market Segments (Product/Channel/Region)
  - 20.4.9.4. Sales Footprint
  - 20.4.9.5. Strategy Overview
    - 20.4.9.5.1. Marketing Strategy
    - 20.4.9.5.2. Product Strategy
- 20.4.10. Syntellix AG
  - 20.4.10.1. Overview
  - 20.4.10.2. Product Portfolio
  - 20.4.10.3. Profitability by Market Segments (Product/Channel/Region)
  - 20.4.10.4. Sales Footprint
  - 20.4.10.5. Strategy Overview
    - 20.4.10.5.1. Marketing Strategy
    - 20.4.10.5.2. Product Strategy
- 20.4.11. Q3 Medical Devices Limited.
  - 20.4.11.1. Overview
  - 20.4.11.2. Product Portfolio
  - 20.4.11.3. Profitability by Market Segments (Product/Channel/Region)
  - 20.4.11.4. Sales Footprint
  - 20.4.11.5. Strategy Overview
    - 20.4.11.5.1. Marketing Strategy
    - 20.4.11.5.2. Product Strategy
- 20.4.12. JW Medical Systems LTD
  - 20.4.12.1. Overview
  - 20.4.12.2. Product Portfolio
  - 20.4.12.3. Profitability by Market Segments (Product/Channel/Region)
  - 20.4.12.4. Sales Footprint
  - 20.4.12.5. Strategy Overview
    - 20.4.12.5.1. Marketing Strategy
    - 20.4.12.5.2. Product Strategy
- 20.4.13. ORBUSNEICH MEDICAL.
  - 20.4.13.1. Overview
  - 20.4.13.2. Product Portfolio
  - 20.4.13.3. Profitability by Market Segments (Product/Channel/Region)
  - 20.4.13.4. Sales Footprint
  - 20.4.13.5. Strategy Overview
    - 20.4.13.5.1. Marketing Strategy
    - 20.4.13.5.2. Product Strategy